Proteinuria has emerged as a potential risk factor for adverse cardiovascular events,
including stroke.1, 2, 3, 4 It has been suggested that proteinuria not only reflects
glomerular damage, but also is a sensitive indicator of systemic factors that initiate
and maintain the atherosclerotic process.5, 6 Diabetes mellitus is among the most
important systemic factors that are associated with atherosclerosis.7, 8, 9
It is well known that albuminuria in diabetic patients is associated with higher risk
of cardiovascular and cerebrovascular events.10 Studies suggest that diabetes mellitus
can cause pathologic changes in blood vessels that predispose to stroke. The major
putative mechanisms by which diabetes mellitus can predispose to stroke are displayed
in the Figure. Still unclear is whether hyperglycemia itself is a risk factor for
stroke.7
Figure 1
Putative mechanism by which stroke occurs in diabetic patients.
One mechanism is proteinuria, which is the topic of the article under discussion.
Proteinuria can increase the risk of stroke through its effects on the coagulation
system, systemic oxidant stress, and inflammation as well as by potentiation of atherosclerosis
and other mechanisms.5 In diabetic patients, other processes, such as hypertension,
hyperlipidemia, vascular congestion, and microvascular and macrovascular disease,
are probably operant.7 In addition, the hyperglycemia itself in diabetics may be involved
through direct and indirect mechanisms.7, 8, 9
A meta‐analysis of 10 observational cohort studies involving 140 231 participants
and 3266 strokes was recently performed.1 Participants with proteinuria had a 71%
greater risk of stroke compared with those without proteinuria (95% CI, 1.39–2.10).
The authors concluded that there was a substantially greater risk of stroke in individuals
with macroalbuminuria than in individuals with microalbuminuria. These findings clearly
support an independent relationship between proteinuria and stroke. Unfortunately,
this and other previous studies typically measured proteinuria only once and focused
on the long‐term effect of such proteinuria on long‐term cardiovascular and cerebrovascular
events. However, proteinuria often changes dynamically, and the impact of proteinuria
on the concurrent risk of stroke was poorly understood11 before the current study
in this issue of the Journal of the American Heart Association (JAHA).
Wang et al12 report on an observational cohort study of 82 938 participants who were
free of myocardial infarction or stroke at the beginning of the study. These subjects
all underwent fasting blood glucose and urinary protein measurements (using dipstick)
at baseline and subsequent follow‐up (annual for the urine dipstick). Time‐dependent
proteinuria was defined as the status of said urine dipstick test updated through
the following year. The prevalences of pre–diabetes mellitus and diabetes mellitus
were 19.69% (n=16 332) and 8.58% (n=7119), respectively. During a median follow‐up
of 8.37 years (interquartile range, 7.91–8.75 years), 2538 participants (3.06%) developed
stroke. Further analysis deemed that 2047 were ischemic, 495 were hemorrhagic stroke,
and only 65 were subarachnoid hemorrhage. Because of the low numbers in the subarachnoid
hemorrhage group, this group was not analyzed independently.
Wang and colleagues found that patients with time‐dependent proteinuria demonstrated
a higher risk for stroke in a dose‐dependent manner.12 Somewhat surprisingly, the
relative risk of stroke was actually higher in nondiabetic and prediabetic patients
compared with those with frank diabetes mellitus. Unfortunately, it is difficult to
ascertain from the data reported whether this represents a greater stroke risk for
those subjects with diabetes mellitus, which is less increased by proteinuria, or
whether the absolute stroke risk is actually higher in nondiabetic proteinuric patients.
On this note, it is believed that the risk of thromboembolism is higher in patients
with some specific forms of nephrotic syndrome, especially those with membranous nephropathy.13
Whether this is because patients with membranous nephropathy have substantially higher
sustained levels of proteinuria than those with other proteinuric renal diseases or
for other reasons (or if it is even true) is still a topic of some debate.14, 15,
16 Stroke risk with proteinuria is believed caused, at least in part, by hypercoagulability
from the glomerular loss of anticoagulants (eg, antithrombin III) along with increased
liver procoagulant synthesis (fibrinogen, factor V, and factor VIII).15, 17 Increased
platelet activation and aggregability, decreased fibrinolytic activity, and localized
clotting activation in the kidney have also been implicated.18
In summary, Wang et al12 reported that time‐dependent proteinuria was actually a more
significant risk factor of stroke in the normoglycemic and prediabetic populations
than those with frank diabetes mellitus. Although these findings clearly support the
concept that proteinuria is an independent risk factor of stroke, further work to
better understand the interactions between the diabetic and proteinuric milieu is
clearly necessary.
Disclosures
None.